Manufacturing of biotechnology products, e.g. monoclonal antibodies and vaccines
- In: S4 - Biotechnology on Tuesday, 4 September 2007, 13:00-16:00
- At: Beijing (China) (2007)
- Type: Presentation
- By: GOMBOTZ, Wayne (Omeros Corporation, Seattle, WA, United States of America)
Biotechnology products have produced medical treatments for some of the most serious diseases. Over 325 million people worldwide have been helped by more than 155 biotechnology drugs and vaccines. The future of biopharmaceutical products is bright. Biologics currently represent only 20% of medicines currently on the market while approximately.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.